AlphaFold predicted structure
CSNK2B · P67870

Mean pLDDT
93.6/ 100
Very high
215 residues
Confidence breakdown
- Very high(≥ 90)87%
- Confident(70–90)7%
- Low(50–70)6%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
casein kinase 2 beta
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPoirier-Bienvenu neurodevelopmental syndrome
neurodegenerative disease
hereditary disease
autosomal dominant non-syndromic intellectual disability
neurodevelopmental disorder
Intellectual disability
autoimmune disorder of central nervous system
Alzheimer disease
Parkinson disease
multiple sclerosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Casein kinase II subunit beta
Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed:11239457, PubMed:16818610). Participates in Wnt signaling (By similarity)
CSNK2B · P67870

Mean pLDDT
93.6/ 100
Very high
215 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0